Losartan Potassium Tablet, Film Coated
NDC 87441-053
Product Information
Losartan Potassium is a ANDA-approved product labeled by Unit Dose Solutions, Inc.. Losartan is used to treat high blood pressure (hypertension) and to help protect the kidneys from damage due to diabetes. It is supplied as a green tablet, film coated for oral administration. This product entry covers the primary NDC 87441-053 and its associated package configuration. This profile includes active and inactive ingredient UNII references and FDA labeling data.
Primary Identification
Clinical Specifications
Labeler & Regulatory Data
Marketing Timeline
Product Characteristics
E;4;6
Code Structure Chart
Product Details
What is NDC 87441-053?
What are the uses of this product?
What are Active Ingredients of this product?
- LOSARTAN POTASSIUM 50 mg/1 - An antagonist of ANGIOTENSIN TYPE 1 RECEPTOR with antihypertensive activity due to the reduced pressor effect of ANGIOTENSIN II.
Which are the associated UNII Codes?
The UNII codes for the active ingredients in this product are:
- LOSARTAN POTASSIUM (UNII: 3ST302B24A)
- LOSARTAN (UNII: JMS50MPO89) (Active Moiety)
Which are the Inactive Ingredients associated UNII Codes?
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:
- MICROCRYSTALLINE CELLULOSE (UNII: OP1R32D61U)
- LACTOSE MONOHYDRATE (UNII: EWQ57Q8I5X)
- STARCH, CORN (UNII: O8232NY3SJ)
- LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE, UNSPECIFIED (UNII: 2165RE0K14)
- MAGNESIUM STEARATE (UNII: 70097M6I30)
- HYDROXYPROPYL CELLULOSE (1600000 WAMW) (UNII: RFW2ET671P)
- HYPROMELLOSE 2910 (6 MPA.S) (UNII: 0WZ8WG20P6)
- TITANIUM DIOXIDE (UNII: 15FIX9V2JP)
- FD&C BLUE NO. 2 (UNII: L06K8R7DQK)
- D&C YELLOW NO. 10 (UNII: 35SW5USQ3G)
- WATER (UNII: 059QF0KO0R)
Which are the Pharmacologic Classes of this product?
* Please review the full disclaimer at the bottom of this page.